Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

Document and Entity Information - shares
9 Months Ended
Jan. 31, 2020
Mar. 13, 2020
Cover [Abstract]    
Entity Registrant Name PharmaCyte Biotech, Inc.  
Entity Central Index Key 0001157075  
Document Type 10-Q  
Document Period End Date Jan. 31, 2020  
Amendment Flag false  
Current Fiscal Year End Date --04-30  
Entity Filer Category Non-accelerated Filer  
Entity Emerging Growth Company false  
Entity Small Business true  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   1,481,471,172
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2020  
Entity Current Reporting Status Yes  
Entity File Number 333-68008  
Entity Incorporation State Code NV  
Entity Interactive data current Yes